Clinical Trial Update: Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is evaluating topical netarsudil to prevent proliferative vitreoretinopathy in patients with Rhegmatogenous Retinal Detachment; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy
• Rhegmatogenous Retinal Detachment

Drugs mentioned

• Netarsudil (netarsudil)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy | Phase 1, Phase 2 | Status: RECRUITING